Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.630
-0.004 (-0.62%)
At close: Dec 20, 2024, 4:00 PM
0.615
-0.015 (-2.38%)
After-hours: Dec 20, 2024, 7:59 PM EST

Cognition Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-34.27-25.79-21.4-11.72-7.84-4.84
Depreciation & Amortization
0.260.250.240.090.10.08
Other Amortization
---0.380.840.49
Stock-Based Compensation
4.294.353.575.180.480.36
Other Operating Activities
0.20.32--0.42-0.070.24
Change in Accounts Receivable
--0.470.120.9-1.08
Change in Accounts Payable
4.252.44-0.752.17-0.360.86
Change in Unearned Revenue
-0.85-1.692.640.5--
Change in Other Net Operating Assets
0.574.09-3.30.062.530.78
Operating Cash Flow
-25.55-16.02-18.53-3.63-3.43-3.1
Capital Expenditures
-0.03-0.15-0.17-0.03-0.01-0.14
Investing Cash Flow
-0.03-0.15-0.17-0.03-0.01-0.14
Long-Term Debt Issued
----5.822.88
Short-Term Debt Repaid
--0.81-1.4-0.27--
Long-Term Debt Repaid
-----0-0.05
Total Debt Repaid
-0.72-0.81-1.4-0.27-0-0.05
Net Debt Issued (Repaid)
-0.72-0.81-1.4-0.275.812.83
Issuance of Common Stock
15.635.496.9461.250.05-
Other Financing Activities
-0.16-0.16--7.78-0.09-0.03
Financing Cash Flow
14.624.525.5553.25.772.79
Foreign Exchange Rate Adjustments
-0-0-0.01-0.02-0.06
Net Cash Flow
-10.96-11.64-13.1649.532.3-0.51
Free Cash Flow
-25.58-16.17-18.7-3.66-3.44-3.24
Free Cash Flow Per Share
-0.70-0.54-0.79-0.70-6.78-6.90
Levered Free Cash Flow
-29.32-23.04-26.27-10.74-8.45-
Unlevered Free Cash Flow
-29.3-23.02-26.25-10.56-8.19-
Change in Net Working Capital
-2.71-4.222.67-2.06-2.12-
Source: S&P Capital IQ. Standard template. Financial Sources.